Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study (Q103738043)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 November 2020
edit
Language Label Description Also known as
English
Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study
scientific article published on 25 November 2020

    Statements

    title
    Efficacy and safety of the long-acting fusion inhibitor albuvirtide in antiretroviral-experienced adults with human immunodeficiency virus-1: interim analysis of the randomized, controlled, phase 3, non-inferiority TALENT study (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    33252379
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33252379%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 December 2020
    author name string

    Identifiers

    PMCID
    7752691
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q103738043&oldid=1936629189"